Published in Transpl Infect Dis on April 07, 2009
Infections in liver transplant recipients. World J Hepatol (2011) 1.14
Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen. PLoS One (2012) 1.02
Invasive fungal infections in solid organ transplant recipients. Future Microbiol (2012) 1.01
Fungal infections in transplant and oncology patients. Infect Dis Clin North Am (2010) 0.96
Bloodstream infections after solid-organ transplantation. Virulence (2016) 0.79
Characterization of Candida parapsilosis complex strains isolated from invasive fungal infections. Eur J Clin Microbiol Infect Dis (2011) 0.79
Disseminated candidiasis 18 years after renal transplantation. Indian J Nephrol (2012) 0.78
Renal allograft pyelonephritis and fungemia due to Candida krusei. Clin Kidney J (2014) 0.75
Candida albicans infections in renal transplant recipients: effect of caspofungin on polymorphonuclear cells. Antimicrob Agents Chemother (2011) 0.75
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality. Transplant Direct (2017) 0.75
Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med (1982) 3.45
Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol (2001) 3.02
Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis (1995) 2.59
Genomewide search for type 2 diabetes susceptibility genes in four American populations. Am J Hum Genet (2000) 2.19
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database Syst Rev (2006) 2.13
Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin). Lancet (1971) 1.93
Cryptococcus neoformans var. gattii in Australia. J Clin Microbiol (1987) 1.92
Fluorescent microsphere-based readout technology for multiplexed human single nucleotide polymorphism analysis and bacterial identification. Hum Mutat (2001) 1.89
Flow cytometric platform for high-throughput single nucleotide polymorphism analysis. Biotechniques (2001) 1.75
Phospholipase activity in Cryptococcus neoformans: a new virulence factor? J Infect Dis (1997) 1.72
A time-motion study of the emergency medical services turnaround interval. Ann Emerg Med (1998) 1.70
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Int J Radiat Oncol Biol Phys (2002) 1.69
A prospective study of adverse reactions associated with vancomycin therapy. J Antimicrob Chemother (1985) 1.64
Concordance of clinical and environmental isolates of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting. J Clin Microbiol (1996) 1.63
Is semiquantitative culture of central vein catheter tips useful in the diagnosis of catheter-associated bacteremia? J Clin Microbiol (1986) 1.60
Campylobacter jejuni: incidence in processed broilers and biotype distribution in human and broiler isolates. Appl Environ Microbiol (1982) 1.56
Wegener's granulomatosis: the relationship between ocular and systemic disease. J Rheumatol (2001) 1.55
Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy. Proc Natl Acad Sci U S A (1999) 1.53
Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur J Clin Microbiol Infect Dis (2003) 1.53
Environmental isolation of Cryptococcus neoformans var. gattii from Eucalyptus tereticornis. J Med Vet Mycol (1992) 1.52
Presence of alpha and a mating types in environmental and clinical collections of Cryptococcus neoformans var. gattii strains from Australia. J Clin Microbiol (1999) 1.51
Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis (1992) 1.49
Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans. Infect Immun (1997) 1.45
Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing. J Clin Microbiol (2006) 1.43
Enzyme amplification for immunoassays. Detection limit of one hundredth of an attomole. J Immunol Methods (1986) 1.41
Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro. Clin Exp Immunol (1975) 1.40
Campylobacter jejuni in broilers: the role of vertical transmission. J Hyg (Lond) (1986) 1.38
Cryptococcosis: clinical and biological aspects. Med Mycol (2000) 1.35
Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J Biol Chem (1994) 1.34
Laboratory identification of Saksenaea vasiformis: a rare cause of zygomycosis in Australia. Sabouraudia (1985) 1.31
Burn wound zygomycosis caused by Apophysomyces elegans. J Clin Microbiol (1990) 1.31
Disseminated candidiasis: evidence of a distinctive syndrome in heroin abusers. Br Med J (Clin Res Ed) (1983) 1.31
Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. Clin Microbiol Infect (2009) 1.28
Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin Microbiol Infect (2009) 1.24
Cryptococcus neoformans var. gattii infection in northern Australia: existence of an environmental source other than known host eucalypts. Trans R Soc Trop Med Hyg (1998) 1.23
Multiplex detection and quantitation of proteins on western blots using fluorescent probes. Biotechniques (2000) 1.19
Purification and characterization of secretory phospholipase B, lysophospholipase and lysophospholipase/transacylase from a virulent strain of the pathogenic fungus Cryptococcus neoformans. Biochem J (2000) 1.19
A cluster of three GABAA receptor subunit genes is deleted in a neurological mutant of the mouse p locus. Nature (1993) 1.19
Susceptibility of Campylobacter jejuni to twenty-three antimicrobial agents. Pathology (1983) 1.18
Identification of pathogenic yeasts of the imperfect genus Candida by polymerase chain reaction fingerprinting. Electrophoresis (1997) 1.17
Characterization of Cryptococcus neoformans by random DNA amplification. Lett Appl Microbiol (1996) 1.15
Isolation of two molecular types of Cryptococcus neoformans var. gattii from insect frass. Med Mycol (2003) 1.14
Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii. Clin Infect Dis (1992) 1.13
Natural environmental sources of Cryptococcus neoformans var. gattii. J Clin Microbiol (1996) 1.13
The cell cycle regulator p27kip1 contributes to growth and differentiation of osteoblasts. Cancer Res (1999) 1.13
Comparison of use of phenotypic and genotypic characteristics for identification of species of the anamorph genus Candida and related teleomorph yeast species. J Clin Microbiol (1997) 1.12
HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology (1992) 1.12
Horizontal transmission of Campylobacter jejuni amongst broiler chicks: experimental studies. Epidemiol Infect (1990) 1.10
Heteronuclear NMR studies of metabolites produced by Cryptococcus neoformans in culture media: identification of possible virulence factors. Magn Reson Med (1999) 1.08
Determinants of mortality in non-neutropenic ICU patients with candidaemia. Crit Care (2009) 1.06
In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1983) 1.06
Endemic fungal infections in the Asia-Pacific region. Med Mycol (2011) 1.05
Mechanism of nonspecific macrophage-mediated cytotoxicity: evidence for lack of dependence upon oxygen. J Immunol (1978) 1.05
Biochemical and functional characterisation of secreted phospholipase activities from Cryptococcus neoformans in their naturally occurring state. J Med Microbiol (1999) 1.04
Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. Int J Pancreatol (2001) 1.03
Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery. Mycoses (2003) 1.02
Identification by random amplification of polymorphic DNA of a common molecular type of Cryptococcus neoformans var. neoformans in patients with AIDS or other immunosuppressive conditions. J Infect Dis (1996) 1.02
Cellulitis due to Pseudomonas putrefaciens: possible production of exotoxins. Rev Infect Dis (1991) 1.02
Skull-base osteomyelitis: fungal vs. bacterial infection. Clin Microbiol Infect (2011) 1.02
Cryptococcomas distinguished from gliomas with MR spectroscopy: an experimental rat and cell culture study. Radiology (2001) 1.02
Fatal Penicillium citrinum pneumonia with pericarditis in a patient with acute leukemia. J Clin Microbiol (1997) 1.02
Systemic sepsis and intravenous devices. A prospective survey. Med J Aust (1984) 1.01
Clinician response to Candida organisms in the urine of patients attending hospital. Eur J Clin Microbiol Infect Dis (2007) 1.01
Antifungal prophylaxis in lung transplantation--a world-wide survey. Am J Transplant (2011) 0.99
Esophageal perforation secondary to angio-invasive Candida glabrata following hemopoietic stem cell transplantation. Clin Microbiol Infect (2003) 0.97
An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital. Br J Cancer (2005) 0.97
Leukotriene B4 omega-oxidation by human polymorphonuclear leukocytes is inhibited by pyocyanin, a phenazine derivative produced by Pseudomonas aeruginosa. Infect Immun (1992) 0.95
Effects of combining propofol and alfentanil on ventilation, analgesia, sedation, and emesis in human volunteers. Anesthesiology (1996) 0.95
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014. Intern Med J (2014) 0.94
PCR fingerprinting: a convenient molecular tool to distinguish between Candida dubliniensis and Candida albicans. Med Mycol (2001) 0.94
A comparison of hospital and community-acquired infective endocarditis. Am J Cardiol (1992) 0.94
Experimental colonization of broiler chicks with Campylobacter jejuni. Epidemiol Infect (1988) 0.93
Feline leprosy: two different clinical syndromes. J Feline Med Surg (2002) 0.93
Recommendations for the treatment of established fungal infections. Intern Med J (2008) 0.93
Partial sequence analysis of the actin gene and its potential for studying the phylogeny of Candida species and their teleomorphs. Int J Syst Evol Microbiol (2001) 0.91
Is the antimicrobial removal device a cost-effective addition to conventional blood cultures? J Clin Pathol (1984) 0.91
Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999-2008. J Hosp Infect (2010) 0.91
Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients. Bone Marrow Transplant (2001) 0.91
Ecology of Cryptococcus neoformans. Rev Iberoam Micol (1997) 0.90
Potential treatment for clubfeet based on growth factor blockade. J Pediatr Orthop (2001) 0.90
A rapid slid coagglutination test-an alternative to the fluorescent antibody test for the identification of Neisseria gonorrhoeae. J Clin Pathol (1981) 0.90
Biliary sepsis. Reviewing treatment options. Drugs (1986) 0.90
Genomic analysis of severe hypersensitivity to hygromycin B reveals linkage to vacuolar defects and new vacuolar gene functions in Saccharomyces cerevisiae. Curr Genet (2009) 0.90
Recombinant interleukin 4 stimulates human immunodeficiency virus production by infected monocytes and macrophages. J Gen Virol (1992) 0.90
Leptospirosis presenting as a haemorrhagic fever in a traveller from Africa. Med J Aust (1997) 0.90
Induction of hepatoma cell apoptosis by c-myc requires zinc and occurs in the absence of DNA fragmentation. Am J Physiol (1996) 0.90
Use of empiric antimicrobial therapy in neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee. Intern Med J (2011) 0.90
Legionella pneumophila lung abscess associated with immune suppression. Intern Med J (2011) 0.89
Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media. J Clin Microbiol (2009) 0.89